Top 20 Cross-Border Healthcare & Medical Tourism Providers 2026

This report forms part of the Ranking News Healthcare Ranking series, which evaluates hospitals, medical institutions, pharmaceutical organizations, medical technology companies, and healthcare systems across global healthcare markets.

Cross-border healthcare and medical tourism providers occupy a growing role within global healthcare as patients increasingly travel internationally for advanced treatment, faster access, lower-cost procedures, specialist expertise, second opinions, and premium hospital services. These providers operate at the intersection of clinical care, international patient coordination, travel logistics, insurance, accreditation, multilingual communication, and post-treatment continuity.

Unlike domestic hospital systems that primarily serve local populations, cross-border healthcare providers must manage the full international patient journey. This includes inquiry handling, remote medical review, visa and travel support, interpreter services, medical records transfer, pricing transparency, care coordination, inpatient and outpatient treatment, discharge planning, follow-up communication, and sometimes coordination with overseas physicians or insurers.

The sector is especially important in markets such as Thailand, Turkey, India, Malaysia, Singapore, South Korea, the United Arab Emirates, Saudi Arabia, and selected European and North American centers. Patients frequently travel for oncology, cardiology, orthopedics, fertility treatment, cosmetic surgery, dental care, bariatric surgery, transplantation-related evaluation, rehabilitation, wellness, diagnostics, and complex second opinions.

This ranking identifies healthcare providers whose cross-border platforms demonstrate sustained relevance across international patient care, clinical capability, medical travel infrastructure, accreditation, reputation, and regional or global reach. Rather than ranking destinations or countries, the objective is to recognize organizations that actively serve international patients through structured medical tourism or cross-border healthcare programs.

Market Overview

The medical tourism and cross-border healthcare market continues to expand as patients seek a combination of quality, affordability, accessibility, and specialization. In lower-cost destination markets, providers attract patients by offering advanced care at prices below those in the United States, Western Europe, or Gulf markets. In premium destination markets, providers attract patients through specialist reputation, advanced technology, academic credibility, and complex care capability.

International accreditation and patient experience standards have become increasingly important. Global Healthcare Accreditation describes its accreditation as external validation that an organization has implemented best practices and rigorous processes for safe, high-quality patient experience for medical travelers and international patients. This reflects the growing importance of structured international patient pathways rather than informal overseas treatment arrangements.

The sector includes several provider types. Large private hospitals such as Bumrungrad International Hospital, Bangkok Hospital, Apollo Hospitals, Anadolu Medical Center, Acibadem, and Gleneagles have developed strong reputations for international patient care. Premium academic or specialist institutions such as Mayo Clinic, Cleveland Clinic, MD Anderson, and Johns Hopkins also serve cross-border patients seeking highly specialized care, though usually at a different cost position.

Regional healthcare hubs continue to shape market demand. Thailand remains one of the most established medical tourism destinations in Asia, supported by private hospitals, international patient centers, wellness services, and hospitality infrastructure. Turkey has become a major destination for medical travel across Europe, the Middle East, Central Asia, and Africa. India remains highly relevant for cardiac care, oncology, transplantation-related services, orthopedics, and cost-sensitive complex care. Singapore, Malaysia, the UAE, and South Korea also maintain important positions in selected specialties and patient segments.

The sector is also becoming more institutionalized. The Medical Tourism Association describes its Global Medical Tourism & Insurance Summit as a gathering of hospital, insurance, employer, travel insurance, and medical tourism facilitator leaders from major regions, highlighting the increasing involvement of insurers, employers, and organized purchasing channels in cross-border healthcare.

Industry Trend — 2026

The cross-border healthcare and medical tourism industry in 2026 is shaped by five major trends: international patient safety, destination competition, specialty differentiation, digital care coordination, and payer involvement.

First, patient safety and accreditation are becoming more important as patients, families, employers, and insurers look for reliable signals of quality. Accreditation bodies focused on medical travel emphasize not only clinical quality but also communication, cultural support, continuity of care, and the international patient experience. GHA’s accredited organization directory illustrates the expanding range of hospitals and providers seeking medical travel-focused validation.

Second, destination competition is intensifying. Thailand, Turkey, India, Malaysia, Singapore, South Korea, the UAE, Saudi Arabia, Mexico, and selected European markets all compete for international patients. Providers must differentiate through specialty depth, pricing transparency, technology, language support, international insurance access, and post-treatment follow-up.

Third, specialty positioning is increasingly important. Medical travelers are no longer limited to basic elective care. Many now seek cancer treatment, heart surgery, robotic surgery, fertility treatment, advanced diagnostics, orthopedics, transplant evaluation, rehabilitation, and complex second opinions. Providers with recognized Centers of Excellence, international patient departments, and physician-led specialty programs are better positioned to attract high-value cross-border demand.

Fourth, digital coordination is becoming central to the patient journey. Leading providers now use remote consultations, online medical record submission, virtual second opinions, digital cost estimates, multilingual case managers, remote follow-up, and international patient portals. These capabilities reduce uncertainty before travel and improve continuity after treatment.

Finally, medical tourism is increasingly linked to insurance, employers, and organized healthcare purchasing. The sector is moving beyond individual self-pay patients toward employer-sponsored programs, international insurance networks, destination partnerships, and government-supported medical travel initiatives. Providers with strong compliance systems, transparent packages, and measurable care pathways are likely to gain advantage.

Methodology — Core Eligibility Criteria

To ensure structural consistency within the category, organizations considered for this ranking were evaluated based on the following eligibility conditions:

• Operates as a hospital, hospital group, specialist medical center, or integrated healthcare provider serving international patients
• Maintains a structured international patient program, medical tourism platform, or cross-border referral capability
• Provides clinical services relevant to international patients, including complex care, specialist treatment, elective procedures, diagnostics, wellness, rehabilitation, or second opinions
• Demonstrates institutional relevance through international patient volume, regional reputation, accreditation, clinical specialization, or medical travel infrastructure
• Maintains systems for language support, care coordination, medical records handling, travel-related assistance, patient safety, and post-treatment communication

Pure travel agencies, non-clinical concierge firms, unverified referral brokers, standalone cosmetic clinics without broad clinical infrastructure, and organizations primarily focused on insurance or tourism rather than healthcare delivery were generally excluded.

Methodology — Ranking Factors

Organizations included in the ranking were evaluated using a combination of qualitative and structural considerations rather than short-term patient volume or marketing visibility alone. Key factors considered include:

• International patient infrastructure and care coordination capability
• Breadth and depth of clinical services relevant to medical travelers
• Reputation in regional or global medical tourism markets
• Accreditation, patient safety systems, and clinical governance
• Specialty programs in areas such as oncology, cardiology, orthopedics, fertility, diagnostics, rehabilitation, and complex surgery
• Multilingual support, pricing transparency, and pre-arrival medical review
• Geographic reach, destination accessibility, and international referral networks
• Institutional stability, brand credibility, and long-term cross-border healthcare relevance

The objective of the ranking is to identify providers whose international patient platforms maintain sustained relevance within the global healthcare ecosystem.

The Healthcare Ranking Top 20 Cross-Border Healthcare & Medical Tourism Providers 2026 ranking evaluates hospitals and healthcare groups serving international patients through medical tourism, cross-border referral, international patient coordination, and global healthcare access programs.

The ranking universe consisted of approximately 120 cross-border healthcare and medical tourism providers globally, from which 20 institutions were selected for inclusion.

Tier classifications reflect relative institutional positioning within the cross-border healthcare and medical tourism provider segment and do not represent clinical outcome rankings, patient recommendations, or investment recommendations.

---

Tier I — Leading Global Cross-Border Healthcare Providers

Bumrungrad International Hospital

• Headquarters: Bangkok, Thailand
• Founded: 1980
• Core focus: International private hospital care, complex specialty care, medical tourism

Bumrungrad International Hospital is one of the world’s most recognized medical tourism providers and a defining institution in Thailand’s international healthcare sector. Located in Bangkok, the hospital has built a long-standing reputation for serving international patients through a combination of private hospital care, multilingual services, specialist medicine, advanced diagnostics, and hospitality-oriented patient coordination.

Bumrungrad’s strength lies in its dedicated international patient model. Its platform is designed for patients traveling from the Middle East, Southeast Asia, South Asia, Europe, North America, and other regions seeking treatment in Thailand. The hospital provides services across cardiology, oncology, orthopedics, neurology, digestive disease, women’s health, wellness, preventive screening, and complex diagnostics.

The institution is frequently cited as one of Southeast Asia’s largest and most internationally recognized private hospitals for medical tourism, with public profiles noting that it treats over one million patients annually and serves international patients from a very broad range of countries. Bumrungrad has also been associated with Global Healthcare Accreditation recognition for medical travel services, reflecting its focus on the international patient experience.

Its combination of brand recognition, international patient infrastructure, specialty breadth, destination appeal, and long-standing medical tourism credibility supports its position as a leading cross-border healthcare provider in 2026.

Apollo Hospitals

• Headquarters: Chennai, India
• Founded: 1983
• Core focus: Tertiary care, complex surgery, international patient services

Apollo Hospitals is one of Asia’s most influential private healthcare groups and a major provider of cross-border healthcare services. The group has played a central role in developing India’s modern private hospital sector and remains highly relevant for international patients seeking advanced care at comparatively lower cost than in many Western markets.

Apollo’s medical tourism platform is supported by a large hospital network, specialist physician base, international patient departments, teleconsultation capabilities, and broad clinical services. The group is particularly relevant in cardiology, cardiac surgery, oncology, transplantation-related care, orthopedics, neurology, robotic surgery, diagnostics, and preventive health.

India’s cost advantage, English-speaking physician base, specialist depth, and large private hospital infrastructure make Apollo a major provider for patients from South Asia, the Middle East, Africa, Southeast Asia, and the Indian diaspora. Public profiles describe Apollo as operating more than 70 hospitals and over 10,000 beds, giving it one of the largest private hospital platforms in Asia.

Apollo’s institutional strength lies in combining scale, clinical complexity, cost competitiveness, and an established international patient brand. These factors support its position among the leading global cross-border healthcare providers.

Anadolu Medical Center

• Headquarters: Kocaeli / Istanbul region, Turkey
• Founded: 2005
• Core focus: Oncology, complex specialty care, international patients

Anadolu Medical Center is one of Turkey’s most recognized international patient hospitals and an important provider in the European, Middle Eastern, Balkan, Central Asian, and CIS medical tourism markets. Its location near Istanbul gives it access to a major international travel hub, while its clinical positioning emphasizes oncology, surgery, transplant-related care, cardiology, neurosciences, and advanced diagnostics.

Turkey has become a major medical tourism destination by combining relatively competitive pricing, experienced private hospitals, specialist physicians, and accessibility from Europe, the Middle East, and Central Asia. Anadolu is one of the providers most closely associated with Turkey’s premium medical travel segment.

The institution’s strength lies in its specialist orientation and international patient infrastructure. Oncology is a particularly important area for cross-border healthcare because patients often seek second opinions, advanced imaging, radiation therapy, surgical oncology, systemic therapy, and multidisciplinary tumor boards outside their home markets.

Anadolu Medical Center’s combination of Turkey’s destination advantages, specialist positioning, international patient services, and regional referral relevance supports its inclusion among leading cross-border healthcare providers.

Acibadem Healthcare Group

• Headquarters: Istanbul, Turkey
• Founded: 1991
• Core focus: Private hospital network, international patient care, specialty services

Acibadem Healthcare Group is one of Turkey’s largest and most recognized private healthcare groups, with a strong presence in the international patient market. The group operates hospitals and medical centers across Turkey and selected international markets, offering services across oncology, cardiology, orthopedics, neurology, transplantation-related programs, diagnostics, surgery, and women’s health.

Acibadem benefits from Turkey’s position as a major medical tourism hub. The country attracts patients from Europe, the Middle East, North Africa, Central Asia, and the Balkans for both complex medical treatment and elective procedures. Acibadem’s hospital network, brand visibility, and multilingual patient services give it a strong platform within this market.

The group’s institutional strength lies in combining hospital scale with international patient coordination. Its network structure allows patients to access a range of specialists, technologies, and hospital sites while benefiting from centralized international services.

Acibadem’s regional influence, specialty breadth, private hospital infrastructure, and established reputation in Turkey’s medical tourism sector support its position as a leading global cross-border healthcare provider.

Bangkok Hospital / Bangkok Dusit Medical Services

• Headquarters: Bangkok, Thailand
• Founded: 1969
• Core focus: Private hospital network, international patient care, specialty medicine

Bangkok Hospital, part of Bangkok Dusit Medical Services, is one of Thailand’s most important medical tourism platforms. BDMS is Thailand’s largest private healthcare provider, and its hospital network includes several brands serving domestic, expatriate, and international patients. Public rating materials describe BDMS as holding a strong market position as Thailand’s largest private healthcare provider with an extensive hospital network.

Bangkok Hospital benefits from Thailand’s strong medical tourism infrastructure, hospitality ecosystem, airport access, and long-standing reputation for private healthcare. The hospital provides services across cardiology, oncology, orthopedics, neurology, rehabilitation, wellness, emergency care, diagnostics, and specialist medicine.

The group’s strength lies in combining destination appeal with clinical network scale. International patients can access private hospital care, interpreter services, concierge support, and specialist programs within a healthcare system already familiar with medical travelers.

Bangkok Hospital and BDMS remain especially relevant for patients from Southeast Asia, the Middle East, China, Australia, Europe, and expatriate communities. Their scale, brand portfolio, and international patient orientation support their Tier I position in this category.

---

Tier II — Established Cross-Border Healthcare Providers

(Alphabetical order)

Asklepios Kliniken International

• Headquarters: Hamburg, Germany
• Founded: 1985
• Core focus: German specialist care, international patient services

Asklepios Kliniken is one of Germany’s major private hospital groups and has developed international patient services for individuals seeking treatment in Germany. Germany remains a relevant destination for cross-border healthcare because of its reputation for specialist medicine, engineering-driven hospital technology, rehabilitation, oncology, orthopedics, and complex diagnostics.

Asklepios’ international relevance lies in its network of hospitals, specialist departments, and ability to coordinate care for patients traveling from Europe, the Middle East, CIS countries, and other regions. Patients seeking treatment in Germany often prioritize technical quality, specialist experience, advanced diagnostics, and rehabilitation pathways.

The group’s strength is its position within a mature European healthcare system. While Germany is usually not the lowest-cost destination, it remains attractive for patients seeking perceived quality, specialist credibility, and complex medical review.

Asklepios Kliniken International’s hospital network, German healthcare positioning, and international patient coordination support its inclusion among established cross-border healthcare provider

Cleveland Clinic Abu Dhabi

• Headquarters: Abu Dhabi, United Arab Emirates
• Founded: 2015
• Core focus: Complex specialty care, regional referral medicine

Cleveland Clinic Abu Dhabi is a major cross-border healthcare provider in the Gulf region, serving patients from the United Arab Emirates and surrounding countries seeking advanced specialty care closer to home. The hospital was developed as part of Abu Dhabi’s strategy to expand access to complex healthcare services within the region.

Its clinical strengths include cardiovascular care, neurological care, digestive disease, respiratory medicine, critical care, surgery, ophthalmology, and complex multispecialty medicine. The Cleveland Clinic brand gives the institution credibility among patients who might otherwise travel to the United States or Europe for advanced treatment.

The hospital’s cross-border relevance lies in regional substitution: it allows Gulf and regional patients to access high-end specialist care without long-distance travel to North America. This is increasingly important as Middle Eastern healthcare systems seek to retain patients domestically or regionally.

Cleveland Clinic Abu Dhabi’s brand connection, advanced clinical platform, and role in regional complex care make it a significant provider in the cross-border healthcare market.

Gleneagles Hospitals / IHH Healthcare

• Headquarters: Kuala Lumpur, Malaysia
• Founded: 1974
• Core focus: Premium hospital care, international patients, regional medical travel

Gleneagles Hospitals, within IHH Healthcare, represent one of Asia’s major premium cross-border healthcare platforms. IHH operates a broad international hospital portfolio, including Gleneagles, Mount Elizabeth, Parkway, Pantai, Acibadem, Fortis, and Prince Court, with operations across multiple countries. IHH describes itself as operating 89 hospitals in 10 countries, giving it one of the most internationalized private healthcare platforms in Asia.

The Gleneagles brand is especially relevant in Singapore, Malaysia, and other Asian markets, where it serves domestic, expatriate, and international patients. Its services include oncology, cardiology, orthopedics, gastroenterology, surgery, diagnostics, women’s health, and preventive screening.

The platform’s strength lies in combining premium hospital brands with regional geographic reach. Patients from Southeast Asia, South Asia, the Middle East, and other regions use IHH hospitals for specialist treatment and private hospital access.

Gleneagles and IHH’s international footprint, premium positioning, and multi-market hospital infrastructure support their position among established cross-border healthcare providers.

Johns Hopkins Medicine International

• Headquarters: Baltimore, United States
• Founded: 1889
• Core focus: Academic medical care, international collaborations, complex referrals

Johns Hopkins Medicine International is a cross-border healthcare platform associated with one of the world’s leading academic medical institutions. While Johns Hopkins is not a low-cost medical tourism provider, it is highly relevant for international patients seeking academic medical expertise, complex second opinions, advanced specialty care, and treatment within a globally recognized medical system.

The institution’s international model includes patient services, clinical programs, education, advisory relationships, and global collaborations. Its reputation in neurology, neurosurgery, oncology, surgery, pediatrics, transplantation, infectious disease, and complex diagnostics supports international demand from patients and referring physicians.

Johns Hopkins’ strength in this category lies in academic credibility rather than destination affordability. For patients seeking high-complexity care, research-based medicine, and specialized physician expertise, the institution remains a major global reference point.

Its international patient services, research reputation, and academic medical brand support its inclusion among established cross-border healthcare providers.

King Faisal Specialist Hospital & Research Centre

• Headquarters: Riyadh, Saudi Arabia
• Founded: 1975
• Core focus: Tertiary and quaternary care, regional complex medicine

King Faisal Specialist Hospital & Research Centre has become an increasingly important regional provider for advanced care in the Middle East. The institution is known for tertiary and quaternary medicine, oncology, transplantation, genetics, cardiac care, and complex specialist services.

Its cross-border relevance is growing as Saudi Arabia invests heavily in healthcare infrastructure, medical innovation, and international patient services. In 2025, KFSHRC announced that it received Global Healthcare Accreditation for medical travel services, indicating formal recognition of its medical travel patient experience processes.

The institution’s strength lies in its advanced clinical services and regional role. Patients from the Gulf, Middle East, and surrounding regions may increasingly view Saudi centers as destinations for complex care, particularly as the country expands healthcare capacity and international positioning.

KFSHRC’s specialist capabilities, research orientation, and medical travel accreditation support its inclusion among established cross-border healthcare providers.

Mayo Clinic International Patient Services

• Headquarters: Rochester, United States
• Founded: 1864
• Core focus: Complex care, second opinions, multispecialty medicine

Mayo Clinic International Patient Services serves patients from around the world seeking advanced diagnosis, complex care, second opinions, and multispecialty treatment. Mayo Clinic’s international relevance is based less on medical tourism affordability and more on global trust in its integrated clinical model.

International patients often seek Mayo Clinic for complex or unresolved cases, cancer care, neurology, cardiology, transplantation evaluation, orthopedics, rare disease workups, executive health, and advanced diagnostics. Mayo Clinic’s physician-led, team-based model is particularly suited to patients requiring coordinated evaluation across multiple specialties.

The institution’s broader Center of Excellence and complex care positioning reinforces its cross-border role. Mayo Clinic markets complex care programs for serious conditions such as cancer, spine surgery, and transplantation, showing how its international and employer-facing models overlap with cross-border healthcare demand.

Mayo Clinic’s global reputation, integrated care model, and international patient infrastructure support its position among established cross-border healthcare providers.

Memorial Healthcare Group

• Headquarters: Istanbul, Turkey
• Founded: 2000
• Core focus: Private hospital care, international medical tourism, specialty services

Memorial Healthcare Group is one of Turkey’s well-known private hospital groups serving international patients. The group operates hospitals and medical centers in Turkey and provides services across organ transplantation-related care, oncology, cardiology, orthopedics, IVF, general surgery, diagnostics, and other specialties.

Turkey’s medical tourism market gives Memorial a strong regional platform. Patients from Europe, the Middle East, North Africa, Central Asia, and neighboring regions often travel to Turkey for private healthcare, combining accessibility, competitive pricing, specialist physicians, and established international patient services.

Memorial’s relevance lies in its brand recognition within Turkey’s medical tourism ecosystem and its capacity to serve both complex and elective patient segments. Its hospitals are positioned for patients seeking private care with multilingual coordination and destination support.

Memorial Healthcare Group’s specialty breadth, Turkish market position, and international patient orientation support its inclusion among established cross-border healthcare providers.

Mount Elizabeth Hospitals / Parkway Pantai

• Headquarters: Singapore
• Founded: 1979
• Core focus: Premium private hospital care, international patients, specialist medicine

Mount Elizabeth Hospitals, part of Parkway Pantai and IHH Healthcare, are among Singapore’s most recognized private hospital brands for international patients. Singapore’s healthcare reputation, regulatory environment, physician base, and regional accessibility make it a premium destination for patients from Southeast Asia, South Asia, China, the Middle East, and expatriate communities.

Mount Elizabeth provides specialist services across oncology, cardiology, orthopedics, neurology, gastroenterology, surgery, women’s health, diagnostics, and executive screening. Its international patient platform benefits from Singapore’s broader reputation for safety, infrastructure, and medical professionalism.

The hospital’s position is different from lower-cost medical tourism destinations. It primarily competes on trust, quality perception, specialist access, and premium private care rather than price alone. This makes it particularly relevant for high-income patients and regional elites seeking treatment in Singapore.

Mount Elizabeth’s brand recognition, IHH platform support, specialist care depth, and Singapore destination advantage support its inclusion among established cross-border healthcare providers.

Raffles Medical Group

• Headquarters: Singapore
• Founded: 1976
• Core focus: Integrated private healthcare, international patients, corporate healthcare

Raffles Medical Group is a Singapore-based integrated private healthcare provider with hospital, clinic, specialist, health screening, and corporate healthcare services. Its platform serves domestic patients, expatriates, international travelers, and corporate clients across Singapore and selected regional markets.

Raffles’ cross-border relevance comes from its integrated model and Singapore location. The group provides specialist consultations, diagnostics, health screening, day procedures, hospital care, and international patient coordination within a trusted regional healthcare hub.

The organization also benefits from strong corporate healthcare and insurance relationships. This is important as cross-border healthcare increasingly involves employers, expatriate plans, international insurance, and organized patient flows rather than only individual medical travelers.

Raffles Medical Group’s integrated care model, Singapore base, international patient services, and corporate healthcare orientation support its position among established cross-border healthcare providers.

Seoul National University Hospital International Healthcare Center

• Headquarters: Seoul, South Korea
• Founded: 1885
• Core focus: Academic medical care, international patients, complex specialty services

Seoul National University Hospital International Healthcare Center represents South Korea’s academic medical contribution to cross-border healthcare. South Korea has developed a strong medical tourism profile in areas such as cancer care, diagnostics, health screening, cosmetic and reconstructive surgery, dermatology, fertility, and advanced specialty medicine.

SNUH’s international relevance lies in combining Korea’s medical technology and specialist expertise with the credibility of a leading national academic hospital. The institution provides complex care, specialist consultations, diagnostics, and academic medical services to international patients.

As medical tourism matures, academic hospitals can differentiate themselves from purely commercial providers by offering research-backed care, multidisciplinary evaluation, and specialist depth. SNUH fits this segment of the market, particularly for patients seeking advanced Korean medical expertise.

Its academic profile, national reputation, and international healthcare center support its inclusion among established cross-border healthcare providers.

---

Tier III — Specialist Cross-Border Healthcare Providers

(Alphabetical order)

• Bangkok International Dental Hospital
• KPJ Healthcare
• Liv Hospital
• Prince Court Medical Centre
• Vejthani Hospital

---

Remarks

Cross-border healthcare and medical tourism providers continue to play a growing role in global healthcare access. Patients travel internationally not only for lower-cost treatment, but also for faster access, specialist expertise, advanced technology, second opinions, premium service environments, and care options unavailable or delayed in their home countries.

The institutions recognized in this ranking represent providers whose international patient platforms maintain sustained relevance across clinical care, medical travel coordination, specialty services, destination infrastructure, and institutional credibility. Tier classification reflects relative positioning within the cross-border healthcare and medical tourism provider sector rather than direct clinical quality rankings.

Tier classification reflects relative international patient infrastructure, clinical breadth, destination relevance, accreditation signals, patient coordination capability, brand recognition, and long-term cross-border healthcare influence. The ranking does not constitute a medical recommendation, patient referral guidance, travel advice, investment recommendation, or evaluation of individual physician performance.

---

Recognition

Organizations included in the Top 20 Cross-Border Healthcare & Medical Tourism Providers 2026 ranking may request information regarding authorized use of the Ranking News designation for marketing and communications purposes.

Recognized institutions may reference the designation in:

• corporate websites
• investor communications
• marketing materials
• institutional presentations
• academic and recruitment materials

Ranking inclusion is editorially determined and independent of licensing, advertising, or commercial participation. Recognition-materials licenses govern only the use of official Ranking News / Healthcare Ranking assets, approved wording, and related communications materials.

Licensing inquiries:
[email protected]